Log in to save to my catalogue

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4348963

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

About this item

Full title

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2014-12, Vol.124 (12), p.5291-5304

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Patients with triple-negative breast cancer (TNBC) have a high incidence of early relapse and metastasis; however, the molecular basis for recurrence in these individuals remains poorly understood. Here, we demonstrate that RASAL2, which encodes a RAS-GTPase-activating protein (RAS-GAP), is a functional target of anti-invasive microRNA-203 and is o...

Alternative Titles

Full title

RASAL2 activates RAC1 to promote triple-negative breast cancer progression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4348963

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4348963

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI76711

How to access this item